Fed. Circ. Revives Galderma Patents Challenged By Teva
A Delaware federal judge was wrong to combine pieces of prior art when finding that claims of three patents covering Galderma's rosacea cream Soolantra were invalid as anticipated, the Federal Circuit...To view the full article, register now.
Already a subscriber? Click here to view full article